Dupilumab for atopic dermatitis linked to lower antibody levels after COVID-19 infection
Benjamin Ungar, MD, and Emma Guttman-Yassky, MD, PhD, discuss their study on how dupilumab for atopic dermatitis is linked to lower antibody levels after COVID-19 infection.

Press Release
New Treatment for Moderate to Severe Atopic Dermatitis Shows Promising Long-Term Results
Dec 09, 2022 View All Press Releases